Cargando…

Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors

DNA sequence and epigenetic information embedded in chromatin must be faithfully duplicated and transmitted to daughter cells during cell division. However, how chromatin assembly and DNA replication are integrated remains unclear. We examined the contribution of the Tousled-like kinases 1 and 2 (TL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sung-Bau, Segura-Bayona, Sandra, Villamor-Payà, Marina, Saredi, Giulia, Todd, Matthew A. M., Attolini, Camille Stephan-Otto, Chang, Ting-Yu, Stracker, Travis H., Groth, Anja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082654/ https://www.ncbi.nlm.nih.gov/pubmed/30101194 http://dx.doi.org/10.1126/sciadv.aat4985

Ejemplares similares

Tousled-Like Kinases Suppress Innate Immune Signaling Triggered by Alternative Lengthening of Telomeres
por: Segura-Bayona, Sandra, et al.
Publicado: (2020)

Molecular basis of Tousled-Like Kinase 2 activation
por: Mortuza, Gulnahar B., et al.
Publicado: (2018)

Synthetic Lethality of Cohesins with PARPs and Replication Fork Mediators
por: McLellan, Jessica L., et al.
Publicado: (2012)

The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment
por: Li, Shuangying, et al.
Publicado: (2022)

Targeting Prostate Cancer, the ‘Tousled Way’
por: Bhoir, Siddhant, et al.
Publicado: (2023)

The protein kinase TOUSLED facilitates RNAi in Arabidopsis
por: Uddin, Mohammad Nazim, et al.
Publicado: (2014)

The Tousled-Like Kinases as Guardians of Genome Integrity
por: De Benedetti, Arrigo
Publicado: (2012)

PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas
por: Navarro, Judith, et al.
Publicado: (2017)

Tousled-like kinases phosphorylate Asf1 to promote histone supply during DNA replication
por: Klimovskaia, Ilnaz M, et al.
Publicado: (2014)

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
por: Mendes-Pereira, Ana M, et al.
Publicado: (2009)

Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
por: Srinivasan, Gayathri, et al.
Publicado: (2017)

DNA damage response and repair data with pharmacological modulators of Tousled
por: Timiri Shanmugam, Prakash Srinivasan, et al.
Publicado: (2016)

Discretionary Transduction of MMP-Sensitized Tousled in Head and Neck Cancer
por: Nair, Renjith Parameswaran, et al.
Publicado: (2019)

Predictors and Modulators of Synthetic Lethality: An Update on PARP Inhibitors and Personalized Medicine
por: Murata, Stephen, et al.
Publicado: (2016)

Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
por: Angers, Stephane
Publicado: (2021)

Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality
por: Le, Bac Viet, et al.
Publicado: (2022)

Untousling the Role of Tousled-like Kinase 1 in DNA Damage Repair
por: Ghosh, Ishita, et al.
Publicado: (2023)

Tousled-Like Kinase-Dependent Phosphorylation of Rad9 Plays a Role in Cell Cycle Progression and G2/M Checkpoint Exit
por: Kelly, Ryan, et al.
Publicado: (2013)

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
por: Bajrami, Ilirjana, et al.
Publicado: (2012)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
por: Asim, Mohammad, et al.
Publicado: (2017)

Combinatorial targeting of Hippo-STRIPAK and PARP elicits synthetic lethality in gastrointestinal cancers
por: An, Liwei, et al.
Publicado: (2022)

Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
por: Chen, Miaoqin, et al.
Publicado: (2022)

Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
por: Brabson, John P., et al.
Publicado: (2023)

mars and tousled-like kinase act in parallel to ensure chromosome fidelity in Drosophila
por: Li, Hsing-Hsi, et al.
Publicado: (2009)

Knockdown of Tousled-like kinase 1 inhibits survival of glioblastoma multiforme cells
por: Ibrahim, Kamariah, et al.
Publicado: (2020)

PARP1 proximity proteomics reveals interaction partners at stressed replication forks
por: Mosler, Thorsten, et al.
Publicado: (2022)

Loss of the abasic site sensor HMCES is synthetic lethal with the activity of the APOBEC3A cytosine deaminase in cancer cells
por: Biayna, Josep, et al.
Publicado: (2021)

Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
por: Oei, Arlene L., et al.
Publicado: (2017)

XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition
por: Patidar, Praveen L., et al.
Publicado: (2020)

The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
por: Turinetto, Margherita, et al.
Publicado: (2021)

Phosphorylation-Mediated Control of Histone Chaperone ASF1 Levels by Tousled-Like Kinases
por: Pilyugin, Maxim, et al.
Publicado: (2009)

The Drosophila Splicing Factor PSI Is Phosphorylated by Casein Kinase II and Tousled-Like Kinase
por: Taliaferro, J. Matthew, et al.
Publicado: (2013)

Replication Checkpoint: Tuning and Coordination of Replication Forks in S Phase
por: Hustedt, Nicole, et al.
Publicado: (2013)

PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA
por: Sugimura, Kazuto, et al.
Publicado: (2008)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

Synthetic lethal genetic interactions between Rad54 and PARP-1 in mouse development and oncogenesis
por: Tanori, Mirella, et al.
Publicado: (2016)

Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
por: Fleury, Hubert, et al.
Publicado: (2019)

Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality
por: Sanese, Paola, et al.
Publicado: (2020)

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
por: Zatreanu, Diana, et al.
Publicado: (2021)

Tousled-like kinase 2 targets ASF1 histone chaperones through client mimicry
por: Simon, Bertrand, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5rnqnj4obdv5bpfkdvmv70s9r8